First Trust Advisors
CTMX icon

First Trust Advisors’s CytomX Therapeutics CTMX Stock Holding History

First Trust Advisors’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.67M Buy
568,562
+145,394
+34% +$738K ﹤0.01% 1790
2025
Q4 		$1.8M Buy
423,168
+21,277
+5% +$80.8K ﹤0.01% 1932
2025
Q3 		$1.28M Buy
+401,891
New +$905K ﹤0.01% 2024
2019
Q2 		– Sell
-24,491
Closed -$263K – 2438
2019
Q1 		$263K Buy
+24,491
New +$362K ﹤0.01% 2298
2018
Q4 		– Sell
-95,805
Closed -$1.77M – 2415
2018
Q3 		$1.77M Sell
95,805
-40,833
-30% -$930K ﹤0.01% 1731
2018
Q2 		$3.12M Buy
+136,638
New +$3.49M 0.01% 1363

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return